General Information of This Drug (ID: DMF1X5P)

Drug Name
Proflavine   DMF1X5P
Synonyms
PRL; Proflavin; Proflavina; Proflavinum; Profura; Progarmed; Isoflav base; Proflavine [INN]; Proflavine hemisulfate; Proflavina [INN-Spanish]; Proflavine Hemi-Sulfate; Proflavinum [INN-Latin]; AE-562/12222295; Acridine-3,6-diamine; 2,8-Diaminoacridine; 2,8-Diaminoacridine (European); 2,8-Diaminoacridinium; 3,6-ACRIDINEDIAMINE; 3,6-Acridinediamine hydrochloride; 3,6-Diamino-acridinium; 3,6-Diaminoacridine; 3,6-Diaminoacridine sulfate; 3,6-Diaminoacridinium; 3,7-Diamino-5-azaanthracene
Indication
Disease Entry ICD 11 Status REF
Sepsis 1G40-1G41 Approved [1]
Therapeutic Class
Antiinfective Agents
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Acetic Acid, Glacial + Proflavine DCZ1OBE Acetic Acid, Glacial Cervical Cancer [2]
------------------------------------------------------------------------------------

References

1 Drug information of Proflavine, 2008. eduDrugs.
2 ClinicalTrials.gov (NCT02335372) Cervical Cancer Screening Study in Brazil